Suppr超能文献

通过序贯促卵泡激素和脉冲式促性腺激素释放激素治疗诱导单卵泡排卵。

Induction of single ovulation by sequential follicle-stimulating hormone and pulsatile gonadotropin-releasing hormone treatment.

作者信息

Kuwahara A, Matsuzaki T, Kaji H, Irahara M, Aono T

机构信息

School of Medicine, Department of Obstetrics and Gynecology, University of Tokushima, Japan.

出版信息

Fertil Steril. 1995 Aug;64(2):267-72. doi: 10.1016/s0015-0282(16)57721-8.

Abstract

OBJECTIVE

To induce single follicular ovulation by sequential treatment with FSH and pulsatile GnRH.

DESIGN

Prospective study.

PATIENTS

Eighteen hypogonadotropic anovulatory patients.

INTERVENTIONS

In sequential treatment, daily FSH injection was switched to pulsatile GnRH administration (20 micrograms/120 minutes SC) when the follicle diameter reached 11 mm. In conventional FSH treatment, daily FSH injection was continued. In both cycles, hCG was given when the diameter of the dominant follicle reached 18 mm.

MAIN OUTCOME MEASURES

Developed follicle numbers and serum FSH concentrations during treatment.

RESULTS

Single follicular development was achieved in 80.0% of cycles by sequential treatment but in no cycle by conventional FSH treatment. The number of developed follicles was 1.26 +/- 0.55 (mean +/- SD) on sequential treatment and 3.94 +/- 1.48 on conventional FSH treatment. Preovulatory FSH level was significantly lower on sequential treatment than on conventional FSH treatment (5.26 +/- 1.80 versus 11.55 +/- 3.43 mIU/mL [conversion factor to SI unit, 1.00]).

CONCLUSION

The sequential treatment achieved single follicular development without complications. The sequential FSH-pulsatile GnRH treatment may offer a better chance for development of a single dominant follicle and ovulation.

摘要

目的

通过促卵泡生成素(FSH)序贯治疗联合脉冲式促性腺激素释放激素(GnRH)诱导单个卵泡排卵。

设计

前瞻性研究。

患者

18例低促性腺激素性无排卵患者。

干预措施

序贯治疗中,当卵泡直径达到11毫米时,将每日注射FSH改为脉冲式GnRH给药(皮下注射20微克/120分钟)。在传统FSH治疗中,继续每日注射FSH。在两个周期中,当优势卵泡直径达到18毫米时给予人绒毛膜促性腺激素(hCG)。

主要观察指标

治疗期间发育卵泡数量和血清FSH浓度。

结果

序贯治疗在80.0%的周期中实现了单个卵泡发育,而传统FSH治疗未出现此情况。序贯治疗时发育卵泡数量为1.26±0.55(平均值±标准差),传统FSH治疗时为3.94±1.48。序贯治疗时排卵前FSH水平显著低于传统FSH治疗(5.26±1.80对11.55±3.43毫国际单位/毫升[转换为国际单位制的换算因子为1.00])。

结论

序贯治疗实现了单个卵泡发育且无并发症。FSH序贯-脉冲式GnRH治疗可能为单个优势卵泡发育和排卵提供更好的机会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验